yolt-204
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2024 (NCT06678165)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07190001 | Early Phase 1 (Phase 1) | Sep 30, 2025 | Guangzhou Medical University |
| NCT06678165 | Early Phase 1 (Phase 1) | Dec 31, 2024 | Hacettepe University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Hacettepe University | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1